H&R GmbH & Co. KGaA (ETR:2HRA)
Germany
· Delayed Price · Currency is EUR 4.560
-0.040 (-0.87%)
Apr 28, 2026, 11:09 PM CET
H&R GmbH & Co. KGaA Revenue
In the year 2025, H&R GmbH & Co. KGaA had annual revenue of 1.25B EUR, down -7.07%. H&R GmbH & Co. KGaA had revenue of 289.25M in the quarter ending December 31, 2025, a decrease of -13.57%.
Revenue
1.25B
Revenue Growth
-7.07%
P/S Ratio
0.14
Revenue / Employee
731.00K
Employees
1,714
Market Cap
169.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.25B | -95.33M | -7.07% |
| Dec 31, 2024 | 1.35B | -14.42M | -1.06% |
| Dec 31, 2023 | 1.36B | -221.97M | -14.01% |
| Dec 31, 2022 | 1.58B | 391.41M | 32.80% |
| Dec 31, 2021 | 1.19B | 314.71M | 35.82% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Masterflex SE | 102.71M |
| Nabaltec AG | 202.27M |
| Uzin Utz SE | 506.39M |
| BRAIN Biotech AG | 49.01M |
| H2APEX Group SCA | 11.06M |
| LANXESS Aktiengesellschaft | 5.67B |
| AlzChem Group AG | 575.05M |
| Verbio SE | 1.73B |